Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Publication of New...
Bernstein Liebhard LLP is investigating Lipitor diabetes lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to Lipitor(PRWeb October 04, 2013)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11198607.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2013 Category: Pharmaceuticals Source Type: news

Statins for Inflamed Gums? (CME/CE)
(MedPage Today) -- In addition to lowering LDL cholesterol, a high dose of atorvastatin may help alleviate periodontal disease, possibly representing a new pleiotropic effect of statins, a small randomized study showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 3, 2013 Category: Cardiology Source Type: news

Is your statin affecting your memory? Study finds some common brands can affect brain function
Researchers at the University of Bristol found that Pravastatin (or Pravachol) has adverse effects on memory but that Lipitor has no effect. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2013 Category: Consumer Health News Source Type: news

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke
(Neural Regeneration Research) A recent study by Lianqiu Min and colleagues from Liaoning Medical University observed the effects of atorvastatin treatment in 89 patients from northeastern China with acute ischemic stroke caused by intracranial large-artery atherosclerosis by measuring changes in the levels of markers of inflammation, thrombogenesis, and hyperlipidemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2013 Category: Global & Universal Source Type: news

Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide...
The Firm is investigating Lipitor lawsuits on behalf of individuals who were treated with this statin drug and later developed Type 2 diabetes and other serious side effects.(PRWeb September 07, 2013)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11099636.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 8, 2013 Category: Pharmaceuticals Source Type: news

CRP as a Predictor of Benefit from AtorvastatinCRP as a Predictor of Benefit from Atorvastatin
Are baseline and on-statin CRP independent predictors of cardiovascular outcome -- beyond low-density lipoprotein cholesterol? Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Reilly announces 30 per cent reduction in cost of anti-cholesterol drug
Atorvastatin, also known as Lipitor, will be set at 70 per cent of the current price     (Source: The Irish Times - Health)
Source: The Irish Times - Health - September 2, 2013 Category: Consumer Health News Source Type: news

Diabetes Sufferers Offered Legal Help By Lancaster Firm
Lipitor, one of the most common and popular drugs in the world, is increasingly being linked to the development of diabetes in women. Numerous reports of adversity have led the Lancaster personal...(PRWeb August 29, 2013)Read the full story at http://www.prweb.com/releases/2013/8/prweb11058583.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 31, 2013 Category: Pharmaceuticals Source Type: news

Lipitor Lawsuit Motion to Consolidate Denied
Levin, Papantonio law firm continues to investigate Lipitor lawsuit claims despite Judge’s decision to deny motion to consolidate.(PRWeb August 19, 2013)Read the full story at http://www.prweb.com/releases/Lipitor-lawsuit/MDL-denied/prweb11036662.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 20, 2013 Category: Pharmaceuticals Source Type: news

Baron and Budd Begins Participation in Lipitor Lawsuit
The National Law Firm Announces Handling of Lipitor Lawsuit Cases Involving the Alleged Development of Type 2 Diabetes in Women Taking the Popular Cholesterol Lowering Drug(PRWeb July 20, 2013)Read the full story at http://www.prweb.com/releases/2013/7/prweb10946708.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 22, 2013 Category: Pharmaceuticals Source Type: news

The Onder Law Firm Offers Lipitor Diabetes Attorney Consultation to...
National pharmaceutical litigation law firm offers confidential case review to Lipitor users who have been diagnosed with diabetes.(PRWeb July 16, 2013)Read the full story at http://www.prweb.com/releases/lawsuit/lipitor-diabetes/prweb10932661.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 18, 2013 Category: Pharmaceuticals Source Type: news

Attorney John J. Driscoll Calls Attention to New Report on Lipitor and...
Lawyer from The Driscoll Firm, P.C., says Lipitor patients may be alarmed and wondering about their legal rights in light of growing medical research associating Lipitor and other statin drugs with a...(PRWeb July 13, 2013)Read the full story at http://www.prweb.com/releases/drug-injury-lawyer/lipitor-and-diabetes-risk/prweb10924527.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 13, 2013 Category: Pharmaceuticals Source Type: news

Well: Ask Well: Women and Statins
Gina Kolata answers a reader’s question about the benefits of taking statins for women.     (Source: NYT Health)
Source: NYT Health - July 11, 2013 Category: Consumer Health News Authors: By GINA KOLATA Tags: Ask Well Cholesterol Lipitor (Drug) medicine and health Statins (Cholesterol-Lowering Drugs) Featured Source Type: news

Injury Lawyers Release New Informational Graphic about the Possible...
d’Oliveira & Associates has released a new infographic on Lipitor including information on recent FDA warnings and medical studies.(PRWeb June 29, 2013)Read the full story at http://www.prweb.com/releases/2013/6/prweb10878253.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 30, 2013 Category: Pharmaceuticals Source Type: news

New Report Examines Efforts To Reduce The Impact Of Generic Competition For Popular Drug Lipitor
AARP's Public Policy Institute have released a new Rx Price Watch report examining efforts by Pfizer to reduce the impact of generic competition for the popular anti-cholesterol drug Lipitor. The report breaks down the unusually aggressive strategy reportedly undertaken by Lipitor's manufacturer before and after the drug's patent expired and discusses how the effort could become a model for other brand name drug manufacturers facing generic competition, ultimately increasing costs for consumers and publicly-funded programs like Medicare and Medicaid... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 15, 2013 Category: Consumer Health News Tags: Public Health Source Type: news